For the apoptosis deficiency in tumor cells, we hypothesized that tumor-specific delivery of FADD or its variant by VNP20009 with the potential to enhance apoptosis and improve the antitumor effect of VNP20009. The gene discussed is FADD; the disease is neoplasm.